Refining risk classification for medulloblastoma using tumor genetics
Part of Cancer clinical trials.
This study looks at the DNA of medulloblastoma (a common childhood brain tumor) to create a better way of classifying the tumor's risk. By understanding the tumor's specific genetic features, doctors hope to tailor treatment more accurately and improve outcomes for children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 6 months and 18 years old.
- Has a confirmed diagnosis of medulloblastoma.
- Has not received prior treatment for the tumor before surgery.
- Had an MRI with contrast of the brain and spine.
- Is generally in good health and able to follow up for a long time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a personalized treatment plan for children and young adults whose medulloblastoma or ependymoma has come back. It aims to guide doctors using new tissue from surgery or biopsy after earlier treatments are fully finished.
This trial is studying the genetic details of medulloblastoma tumors in children to find new, targeted treatments. If your child had surgery for medulloblastoma at our pediatric center, their tumor tissue may help us learn more.
This trial tests a combination of chemotherapy drugs (topotecan given into the spine plus maintenance chemo) for children under 6 with high-risk embryonal brain tumors. The goal is to see if this approach can improve outcomes after initial treatment.
This study looks at genetic (DNA/molecular) features of malignant brain tumors in children. It may help doctors better understand tumor risk patterns and guide future treatment planning.
This Phase 2 trial tests how doctors choose treatment for infants and young children with newly diagnosed medulloblastoma, based on MRI/CSF staging and lab testing of the tumor. It may help by matching therapy intensity to the child’s specific risk level and tumor type.
This trial observes where medulloblastoma tumors first appear and how they grow during surgery. It helps doctors better understand these rare childhood and adult brain tumors.
Hear when a new Medulloblastoma, Childhood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.